Minimum inhibitory concentration, or MIC, is the lowest concentration of an antibiotic that completely stops a bacterial strain from growing in a lab setting. It’s expressed in milligrams per liter (mg/L) and serves as the standard measurement for how potent an antibiotic is against a specific organism. Every time a doctor chooses an antibiotic and decides on a dose, MIC values are part of the reasoning behind that decision, even if you never hear the term during your appointment.
How MIC Is Measured
The core idea is straightforward: expose bacteria to a series of increasingly diluted antibiotic concentrations and find the point where growth stops entirely. In practice, this happens in one of three main ways.
The gold-standard method is called broth microdilution. A lab technician prepares a row of tiny wells, each containing liquid growth medium with a different concentration of antibiotic, typically doubling with each step (1, 2, 4, 8, 16 mg/L, and so on). A standardized number of bacteria is added to every well, and the tray is incubated overnight. The next morning, the first well in the series that shows no visible cloudiness (meaning no bacterial growth) is the MIC. Some labs add a dye called resazurin to make reading easier. Living bacteria convert this blue dye to pink, so a well that stays blue contains no active bacteria.
A second approach uses agar plates instead of liquid. Antibiotic is mixed into solid growth medium at various concentrations, bacteria are streaked onto the surface, and the plate with the lowest concentration showing no colonies is the MIC. A stray colony or two, or a faint haze, is disregarded.
A third method, gradient diffusion, uses a plastic strip infused with a continuous gradient of antibiotic from high concentration at one end to low at the other. The strip is placed on an agar plate covered in bacteria. As the antibiotic diffuses outward, it creates an elliptical zone where nothing grows. The point where the edge of bacterial growth intersects the strip gives you the MIC value. If the bacteria are fully resistant, no ellipse forms at all. When growth falls between two printed values on the strip, the higher number is used.
Automated Systems in Modern Labs
Most hospital laboratories no longer read MIC results by eye. Automated platforms handle the inoculation, incubation, and reading steps with minimal hands-on time. The most widely used system globally is the Vitek 2, followed by the Phoenix and MicroScan platforms. These machines standardize the process and reduce turnaround time, but they aren’t perfect. Studies comparing automated systems have found that a considerable proportion of results fall outside acceptable ranges, sometimes due to technicians not following standardized procedures and sometimes due to the systems themselves producing inaccurate readings at low bacterial counts.
What the Numbers Mean Clinically
A raw MIC number on its own doesn’t tell you much. An MIC of 4 mg/L might mean “easily treatable” for one antibiotic and “resistant” for another, because different drugs reach different concentrations in the body. To make sense of MIC values, expert committees set clinical breakpoints: threshold concentrations that sort bacteria into categories.
The two major organizations that define these breakpoints are CLSI (used primarily in the United States) and EUCAST (used across Europe and increasingly worldwide). Both classify bacteria into three categories based on where the MIC falls relative to the breakpoint:
- Susceptible (S): The antibiotic is expected to work at standard doses.
- Susceptible, increased exposure (I): The antibiotic may work, but only with higher doses or more frequent dosing.
- Resistant (R): The antibiotic is unlikely to work regardless of dose.
These breakpoints are updated regularly. EUCAST, for example, publishes new tables annually, with the current version (v16.0) covering 2026. Breakpoints can shift as new data emerges about how drugs behave in the body or as resistance patterns change.
MIC50 and MIC90: Tracking Resistance
When researchers want to describe how well an antibiotic works against a whole population of bacteria rather than a single isolate, they use two summary statistics. MIC50 is the concentration needed to inhibit growth in 50% of all tested isolates, and MIC90 is the concentration that handles 90%. These numbers are especially useful for tracking resistance trends over time. If the MIC90 for a particular antibiotic creeps upward year after year, it signals that the bacterial population is becoming less susceptible, even if individual isolates still technically fall in the “susceptible” category.
This phenomenon, sometimes called MIC creep, has real consequences. Research on the antibiotic vancomycin, commonly used for serious staph infections, has linked gradual MIC increases to poorer clinical outcomes and higher mortality, even when the bacteria technically remain classified as susceptible.
How MIC Guides Antibiotic Dosing
Doctors and pharmacists use MIC values alongside information about how a drug moves through your body to optimize dosing. The goal is to ensure the antibiotic reaches and maintains concentrations high enough to kill the bacteria at the infection site, while minimizing side effects and reducing the chance that resistant strains emerge.
Different classes of antibiotics kill bacteria in different ways, and the relationship between drug concentration and bacterial killing varies accordingly. Three key ratios tie MIC to dosing decisions:
- Time above MIC: For antibiotics like penicillins and cephalosporins, what matters most is how long the drug concentration in your blood stays above the MIC. This is why these drugs are often given multiple times a day or as continuous infusions.
- Peak concentration divided by MIC: For aminoglycosides, the height of the peak drug level relative to the MIC matters most. These drugs are often given as a single large daily dose.
- Total drug exposure divided by MIC: For fluoroquinolones, the overall amount of drug exposure over 24 hours relative to the MIC best predicts effectiveness. Research on the fluoroquinolone moxifloxacin, for instance, found that a specific threshold of total exposure relative to MIC was required for the drug to achieve a bactericidal effect.
This kind of MIC-guided dosing has measurable clinical impact. Patients infected with Salmonella strains that have ciprofloxacin MICs between 0.125 and 1.0 mg/L experience more treatment failures and take longer to recover from fever than patients whose infections have fully susceptible MICs below 0.06 mg/L. That sixteenfold difference in MIC translates directly into worse outcomes.
Why MIC Results Can Vary
MIC testing is standardized, but several variables can shift results. The most well-known is the inoculum effect: the number of bacteria you start with changes the result. The recommended starting concentration is about 500,000 bacterial cells per milliliter, with an acceptable range of 200,000 to 800,000. Even minor deviations from this range can dramatically alter the observed MIC, particularly for bacteria that produce enzymes capable of breaking down the antibiotic. When more bacteria are present, they collectively produce more of these enzymes, effectively neutralizing the drug and making the MIC appear higher than it would be under standard conditions.
Other factors that influence results include the pH of the growth medium, incubation temperature, and the length of time before results are read. This is why standardized protocols exist and why quality control strains with known MIC values are tested alongside clinical samples. Even so, studies of large hospital networks have found that quality control results are “barely satisfactory” across all major automated platforms, highlighting that MIC is best understood as an approximate measurement rather than a precise one. A single dilution step difference (say, 2 versus 4 mg/L) is within the normal margin of error for the test.